Effective Drug Development Strategies
Date
Thursday June 4, 202612:00 pm - 1:00 pm
Drug development is a complex process that inherently involves intricate challenges. Introduction of new regulatory policies, cutting-edge technologies, and evolving perspectives on animal research are reshaping strategies in drug development. Please join us for an interactive lunchtime seminar where we will discuss opportunities for strategy refinement to:
- Enhance chances of clinical success during the drug discovery phase
- Leverage in vivo pharmacology for proof-of-concept data
- Adopt new technologies to accelerate timelines
- Focus on key elements in your IND strategy
- Maximize your relationship with your CRO
Lunch will be provided for attendees.
1-on-1 meetings (1-3pm): Following the talk, Samuel will have limited sessions available for 1-on-1 meetings with faculty interested in discussing their drug development in greater detail. Please sign up via the registration link.
Register for this session
For questions, please contact Marissa Stein.
Speaker Information

Samuel S. Chuang, PhD
Executive Director, Scientific Advisory Services
Charles River Laboratories
Sam leads a global team of scientists with extensive regulatory and scientific experience in drug development. He has over 25 years of academic, biotechnology and nonclinical CRO research experience. Sam collaborates with biotechnology and pharmaceutical companies, medical and research institutions, and academics worldwide, by creating, advising, and monitoring nonclinical regulatory safety programs. He provides scientific and regulatory expertise covering a wide range of drug classes (new chemical entities, new biological entities, advanced therapies, 505(b)2 packages, excipient developments, vaccines, medical devices, etc.) across a variety of therapeutic areas. Sam also provides strategic advice and support to various advisory councils and international working groups.
Sam is also a scientific advisory board member for Charles River, helping to guide Charles River’s strategic focus on New Approach Methodologies (NAMs).